{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:36:27Z","timestamp":1792089387939,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nucmedbio.2025.109596","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:36:32Z","timestamp":1764894992000},"page":"109596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer"],"prefix":"10.1016","volume":"152-153","author":[{"given":"Michael R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia G.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Heidari-Kharaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Sikligar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian A.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Schaedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Golzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Watkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry L.","family":"Carmack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni M.","family":"Lunceford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Talbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Maitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109596_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0010","article-title":"DNA damage response inhibitors: an avenue for TNBC treatment","volume":"1875","author":"Jin","year":"2021","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1596","article-title":"Ammonium tetrathiomolydate in the decoppering phase treatment of Wilson\u2019s disease with neurological symptoms: a case series","volume":"10","author":"De Fabregues","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.1179907","article-title":"Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation","volume":"327","author":"Alvarez","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0025","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","article-title":"Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis","volume":"12","author":"Ramchandani","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0030","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/biomedicines9121887","article-title":"Evaluation of ATOX1 as a potential predictive biomarker for tetrathiomolybdate treatment of breast cancer patients with high risk of recurrence","volume":"9","author":"Blockhuys","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-021-00313-w","article-title":"Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer","volume":"7","author":"Liu","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-375","article-title":"Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate","volume":"10","author":"Joimel","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1534735405282475","article-title":"Multifocal angiostatic therapy: an update","volume":"4","author":"McCarty","year":"2005","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0050","first-page":"4854","article-title":"Copper defiency induced by tetrthiomolybdate suppresses tumor growth and angiogenesis","volume":"62","author":"Pan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0055","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1535-7163.MCT-18-0667","article-title":"Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and supresses tumor angiogenesis","volume":"18","author":"Karginova","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0060","first-page":"701","article-title":"Tetrathiomolybdate inhibits angiogenesis and metastasis through supression of the NFKB signaling cascade","volume":"1","author":"Pan","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0065","doi-asserted-by":"crossref","first-page":"84439","DOI":"10.18632\/oncotarget.12992","article-title":"Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin","volume":"7","author":"Chisholm","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0070","first-page":"617","article-title":"Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma","volume":"2","author":"Pan","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0075","first-page":"17","article-title":"Cat mammary tumors: genetic models for the human counterpart","volume":"3","author":"Adega","year":"2016","journal-title":"Vet Sci"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2967\/jnumed.107.045138","article-title":"Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates","volume":"49","author":"Jia","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.2557","article-title":"A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence: updated results","volume":"35","author":"Sahota","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13550-017-0346-4","article-title":"Biodistribution and radiation dosimetry of [64Cu]copper dichloride: first-in-human study in healthy volunteers","volume":"7","author":"Avila-Rodriguez","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0100","article-title":"Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper pet\/ct","volume":"5","author":"Kj\u00e6gaard","year":"2020","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0105","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12149-020-01522-2","article-title":"Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic","volume":"34","author":"Chakravarty","year":"2020","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/RLU.0000000000003658","article-title":"Efficacy and safety of the 64Cu(II)Cl2 PET\/CT for urological malignancies","volume":"46","author":"Mascia","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0009-2797(99)00159-3","article-title":"Excretion of copper complexed with thiomolybdate into the bile and blood in LEC rats","volume":"124","author":"Komatsu","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.nucmedbio.2025.109596_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0162-0134(99)00218-4","article-title":"Metabolic fate of the insoluble copper\/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate","volume":"78","author":"Ogra","year":"2000","journal-title":"J Inorg Biochem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:33:06Z","timestamp":1777602786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125006055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S0969805125006055"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109596","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109596"}}